His primary areas of study are Microbiology, Helicobacter pylori, Antigen, Virulence and Virology. His Microbiology research is multidisciplinary, relying on both Pilus shaft, Pilus, Pathogenicity island and Streptococcus agalactiae. The various areas that he examines in his Pilus study include Streptococcus and Bacteria.
His Helicobacter pylori study deals with Immunology intersecting with Stimulation. His work in Antigen addresses subjects such as CagA, which are connected to disciplines such as Immune system. His Virulence study combines topics from a wide range of disciplines, such as Secretion, Peptide sequence, Group A and Peptide.
John L. Telford mainly focuses on Microbiology, Molecular biology, Biochemistry, Virology and Helicobacter pylori. The Microbiology study combines topics in areas such as Pilus, Virulence and Streptococcus, Streptococcus agalactiae, Bacteria. His studies deal with areas such as Serotype, Group B and Genome as well as Streptococcus agalactiae.
His research integrates issues of Cell culture, Jurkat cells, Signal transduction, Protein kinase C and Gene in his study of Molecular biology. His Virology study combines topics in areas such as Bacterial vaccine, Computational biology, Recombinant DNA and Antigen. Within one scientific family, John L. Telford focuses on topics pertaining to Immunology under Helicobacter pylori, and may sometimes address concerns connected to Disease.
His main research concerns Microbiology, Virology, Streptococcus agalactiae, Pilus and Biochemistry. His Microbiology research focuses on Serotype in particular. John L. Telford has included themes like Bacterial vaccine, Recombinant DNA, Proteases, Antigen and Computational biology in his Virology study.
His Antigen research includes elements of Proteome and Peptide sequence. His Streptococcus agalactiae study integrates concerns from other disciplines, such as Tetracycline, Sialic acid, Catabolism, Group B and Vaccination. His Pilus research is multidisciplinary, incorporating perspectives in Transferase and Bacteria.
John L. Telford mostly deals with Streptococcus agalactiae, Virology, Streptococcus, Microbiology and Serotype. His Streptococcus agalactiae study incorporates themes from Tetracycline and Group B. His work deals with themes such as Proteome, Bacterial vaccine, Computational biology and Antigen, which intersect with Virology.
His Antigen research integrates issues from Antibody, Recombinant DNA, Sequence alignment and Biochemistry. His research in Streptococcus intersects with topics in Proteases, Mass screening and Biofilm. His study looks at the relationship between Biofilm and topics such as Fimbriae Proteins, which overlap with Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial “pan-genome”
Hervé Tettelin;Vega Masignani;Michael J. Cieslewicz;Claudio Donati.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Helicobacter pylori virulence and genetic geography.
Antonello Covacci;John L. Telford;Giuseppe Del Giudice;Julie Parsonnet.
ANALYSIS OF EXPRESSION OF CAGA AND VACA VIRULENCE FACTORS IN 43 STRAINS OF HELICOBACTER PYLORI REVEALS THAT CLINICAL ISOLATES CAN BE DIVIDED INTO TWO MAJOR TYPES AND THAT CAGA IS NOT NECESSARY FOR EXPRESSION OF THE VACUOLATING CYTOTOXIN
Zhaoying Xiang;Stefano Censini;Pietro F. Bayeli;John L. Telford.
Infection and Immunity (1995)
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J L Telford;P Ghiara;M Dell'Orco;M Comanducci.
Journal of Experimental Medicine (1994)
T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.
M M D'Elios;M Manghetti;M De Carli;F Costa.
Journal of Immunology (1997)
Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Domenico Maione;Immaculada Margarit;Cira D. Rinaudo;Vega Masignani.
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.
Hervé Tettelin;Vega Masignani;Michael J. Cieslewicz;Jonathan A. Eisen;Jonathan A. Eisen.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Pili in Gram-positive pathogens
John L. Telford;Michèle A. Barocchi;Immaculada Margarit;Rino Rappuoli.
Nature Reviews Microbiology (2006)
Correction: Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline
Violette Da Cunha;Mark R. Davies;Pierre-Emmanuel Douarre;Isabelle Rosinski-Chupin.
Nature Communications (2015)
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome
Manuel J Rodríguez-Ortega;Nathalie Norais;Giuliano Bensi;Sabrina Liberatori.
Nature Biotechnology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: